Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Bioarray Genetic Diagnosis logo — The one-stop Lab for Reproductive & Medical Genetics

Bioarray Genetic Diagnosis

The one-stop Lab for Reproductive & Medical Genetics

Founded 2008 Spain Spain 56 employees Biotechnology, Health Care +1

General Information

Company Name Bioarray Genetic Diagnosis
Founded Year 2008
Location Spain Spain
Employees 56
Industries Biotechnology, Health Care, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Bioarray Genetic Diagnosis. To contact Bioarray Genetic Diagnosis, visit bioarray.es.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bioarray Genetic Diagnosis compare?

A PDF of Bioarray Genetic Diagnosis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bioarray Genetic Diagnosis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bioarray Genetic Diagnosis

Bioarray Genetic Diagnosis is a leading genetic testing provider based in Spain, catering to clinical partners across Europe, Latin America, MENA, and Asia. Established in 2008, the company specializes in array CGH and NGS technologies for medical genetics, reproductive genetics, and oncology-related testing. Their services include WES, WGS, expanded carrier screening, preimplantation genetic testing (PGT), and somatic and germline tests, among others. Additionally, Bioarray offers research services such as gene expression studies based on array or RNA-seq. The company's sister concern, Journey Genomics, introduced PGD-Seq™, a pioneering kit for library preparation and data analysis, designed to streamline the implementation of PGT-M in NGS labs. The company operates in the biotechnology, health care, and pharmaceutical industries and is positioned as a one-stop lab for reproductive and medical genetics. It is worth noting that there is no publicly available information on Bioarray's last investment or the involved investors. However, with its comprehensive portfolio and strategic positioning, the company presents an intriguing opportunity for potential investors seeking exposure to the rapidly evolving field of genetic diagnostics and research.

Business keywords: Genetic Testing, Medical Genetics, Reproductive Genetics, NGS, Array CGH, WES, WGS, PGT, Endometrial Receptivity, Prenatal Diagnosis, Oncology, Somatic Testing, Germline Testing, Liquid Biopsy, Research Services

No funding data available for Bioarray Genetic Diagnosis yet.

Bioarray Genetic Diagnosis Alternatives & Competitors

View All Alternatives
Bioarray Genetic Diagnosis vs
G2M | Next Generation IVD solutions for Genomics
G2M | Next Generation IVD solutions for Genomics India

Revolutionizing Molecular Diagnostics with world-class Innovative IVD Solutions.

103 employees
Biotechnology, Health Care
Bioarray Genetic Diagnosis vs
LCM Genect
LCM Genect Italy

Enable precision medicine

6 employees
Biopharma, Biotechnology
Bioarray Genetic Diagnosis vs
3billion
3billion Korea South

Your One Answer Genetic testing for rare diseases made more efficient and more accessible

Series C
68 employees
Health Care, Pharmaceutical
View all alternatives

FAQ About Bioarray Genetic Diagnosis

The one-stop Lab for Reproductive & Medical Genetics
Bioarray Genetic Diagnosis was founded in 2008.
Bioarray Genetic Diagnosis is headquartered in Spain.
Bioarray Genetic Diagnosis operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Genetic Testing, Medical Genetics, Reproductive Genetics and NGS.
Bioarray Genetic Diagnosis has approximately 56 employees.
Top alternatives and competitors to Bioarray Genetic Diagnosis include G2M | Next Generation IVD solutions for Genomics, LCM Genect, 3billion, CGC Genetics / CGC Centro Genetica Clinica, Variantyx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bioarray Genetic Diagnosis and G2M | Next Generation IVD solutions for Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bioarray Genetic Diagnosis, https://bouncewatch.com/company/bioarray-genetic-diagnosis, updated 4 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes